Doxycycline promotes carcinogenesis & metastasis via chronic inflammatory pathway: An in vivo approach

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Nanda, Neha ^a,b   Dhawan, Devinder K ^b   Bhatia, Alka ^a   Mahmood, Akhtar ^b   Mahmood, Safrun ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; DOXYCYCLINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; VASCULOTROPIN; 1,2 DIMETHYLHYDRAZINE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CHRONIC INFLAMMATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; METASTASIS; NONHUMAN; PRACTICE GUIDELINE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; ANIMAL; BODY WEIGHT; CARCINOGENESIS; CELL PROLIFERATION; CHEMICALLY INDUCED; CHRONIC DISEASE; COLON TUMOR; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BODY WEIGHT; CARCINOGENESIS; CASPASE 3; CASPASE 9; CELL PROLIFERATION; CHRONIC DISEASE; COLONIC NEOPLASMS; CYTOCHROMES C; DOWN-REGULATION; DOXYCYCLINE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE, SMALL; MALE; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; NF-KAPPA B; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84962339179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151539     Document Type: Article

References (51)

1. American Cancer Society. Colorectal Cancer Facts & Figures 2014-2016. Atlanta: American Cancer Society, 2014.
2. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-17. doi: 10.3322/caac.21220 PMID: 24639052
3. Sagar J. Doxycycline in clinical Medicine. Clin Med Insights Ther. 2010; 2: 133-136.
4. Mouratidis PXE, Colston KW, Dalgleish AG. Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells. Int J Cancer. 2006; 120: 743-752.
5. Duivenvoorden WCM, Vukmirovic-Popovic S, Kalina M, Seidlitz E, Singh G. Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer. Br J Cancer. 2007; 96: 1526-1531. PMID: 17437017
6. Onoda T, Ono T, Dhar DK, Yamanoi A, Nagasue N. Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells. Int J Cancer. 2006; 118: 1309-1315. PMID: 16152604
7. Sagar J, Sales K, Taanman JW, Dijk S, Winslet M. Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria. Cancer Cell Int. 2010; 10: 31. doi: 10.1186/1475-2867-10-31 PMID: 20819205
8. Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, Nagasue N. Doxycycline inhibits cell proliferation and invasive potential: Combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med. 2004; 143: 207-216. PMID: 15085079
9. Veeramachaneni NK, Lin L, Pippin JA, Winslow ER, Drebin JA. Doxycycline and indomethacin synergistically down-regulate beta-catenin signaling and inhibit colon cancer cell growth. J Surgical Res. 2003; 114: 251-2.
10. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis. 1999; 20: 1425-1431. PMID: 10426787
11. Chadha VD, Vaiphei K, Dhawan DK. Zinc mediated normalization of histoarchitecture and antioxidant status offers protection against initiation of experimental carcinogenesis. Mol Cell Biochem. 2007; 304: 101-8. PMID: 17530192
12. Kovács Z, Kékesi KA, Baracskay P, Juhász G, Czurkó A. Doxycycline could aggravate the absencelike epileptic seizures of WAG/Rij rats via matrix metalloproteinase inhibition. Neurochem Int. 2011; 59: 563-6. doi: 10.1016/j.neuint.2011.06.016 PMID: 21740942
13. Sun B, Zhang S, Zhang D, Yin X, Wang S, Gu Y, et al. Doxycycline influences microcirculation patterns in B16 melanoma. Exp Biol Med (Maywood). 2007; 232: 1300-7.
14. Pettan-Brewer C, Morton J, Cullen S, Enns L, Kehrli KR, Sidorova J, et al. Tumor growth is suppressed in mice expressing a truncated XRCC1 protein. Am J Cancer Res. 2012; 2: 168-77. PMID: 22432057
15. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008; 3(5).
16. Wu S, Rhee KJ, Albesiano E, Rabizadeh S,Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009; 15: 1016-22. doi: 10.1038/nm.2015 PMID: 19701202
17. Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples. PLoS ONE. 2014; 9: E96801 doi: 10.1371/journal.pone.0096801 PMID: 24802416
18. Megaraj V, Ding X, Fang C, Kovalchuk N, Zhu Y, Zhang QY. Role of hepatic and intestinal p450 enzymes in the metabolic activation of the colon carcinogen azoxymethane in mice. Chem Res Toxicol. 2014; 27: 656-62. doi: 10.1021/tx4004769 PMID: 24552495
19. Fiala ES, Sohn OS, Puz C, Czerniak R. Differential effects of 4-iodopyrazole and 3-methylpyrazole on the metabolic activation of methylazoxymethanol to a DNA methylating species by rat liver and rat colon mucosa in vivo. J Cancer Res Clin Oncol. 1987; 113: 145-50. PMID: 3558452
20. Dance-Barnes ST, Kock ND, Moore JE, Lin EY, Mosley LJ, D'Agostino RB Jr, et al. Lung tumor promotion by curcumin. Carcinogenesis. 2009; 30: 1016-23. doi: 10.1093/carcin/bgp082 PMID: 19359593
21. Tahan V, Sayrak H, Bayar N, Erer B, Tahan G, Dane F. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J. 2008; 1: 144. doi: 10.1186/1757-1626-1-144 PMID: 18778470
22. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-?B as the matchmaker. Nat Immunol. 2011; 12: 715-723. doi: 10.1038/ni.2060 PMID: 21772280
23. Panico A, Maccari R, Cardile V, Avondo S, Crascì L, Ottanà R. Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures. Med Chem Commun. 2015; 6: 823-830.
24. Shostak K, Chariot A. EGFR and NF-?B: Partners in cancer. Trends Mol Med. 2015; 21: 385-93. doi: 10.1016/j.molmed.2015.04.001 PMID: 25979753
25. Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of treg-mediated T cell suppression. Front Immunol. 2012; 3: 51. doi: 10.3389/fimmu.2012.00051 PMID: 22566933
26. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappa B collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010; 21: 11-9. doi: 10.1016/j.cytogfr.2009.11.005 PMID: 20018552
27. Walker SR, Xiang M, Frank DA. STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b. Cancers (Basel). 2014; 6: 958-68.
28. Liu X, Ye L, Bai Y, Mojidi H, Simister NE, Zhu X. Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG. J Immunol. 2008; 181: 449-63. PMID: 18566411
29. Rui L, Schmitz R, Ceribelli M, Staudt LM. Malignant pirates of the immune system. Nat Immunol. 2011; 12: 933-40. doi: 10.1038/ni.2094 PMID: 21934679
30. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, et al. NF-kappaB and AP-1 connection: Mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol. 2004; 24: 7806-19. PMID: 15314185
31. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: An immunologist's guide to reactive oxygen species. Nat Rev Immunol. 2013; 13: 349-61. doi: 10.1038/nri3423 PMID: 23618831
32. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-?B signaling. Cell Res. 2011; 21: 103-15. doi: 10.1038/cr.2010.178 PMID: 21187859
33. Wang F, Yang JL, Yu KK, Xu M, Xu YZ, Chen L, et al. Activation of the NF-?B pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma. Mol Cancer. 2015; 14: 10. doi: 10.1186/s12943-014-0274-0 PMID: 25622857
34. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980; 284: 67-68. PMID: 6243750
35. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000; 2: 737-44. PMID: 11025665
36. Pozzi A, LeVine WF, Gardner HA. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Oncogene. 2002; 21: 272-281. PMID: 11803470
37. Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, et al. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int J Cancer. 2005; 116: 52-61. PMID: 15756690
38. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001; 132: 8-13. PMID: 11438047
39. Akkaya P, Onalan G, Haberal N, Bayraktar N, Mülayim B, Zeyneloglu HB. Doxycycline causes regression of endometriotic implants: A rat model. Hum Reprod. 2009; 24: 1900-1908. doi: 10.1093/humrep/dep106 PMID: 19401321
40. Nakanishi C, Toi M. Nuclear factor-kappa B inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer. 2005; 5: 297-309. PMID: 15803156
41. Jubb AM, Oates AJ, Holden S, Koeppen H. Predicting benefit from antiangiogenic agents in malignancy. Nat Rev Cancer. 2006; 6: 626-635. PMID: 16837971
42. Fainaru O, Adini I, Benny O, Bazinet L, Pravda E, D'Amato R, et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J. 2008; 22: 3728-35. doi: 10.1096/fj.08-110494 PMID: 18606869
43. Karin M, Greten FR. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005; 5: 749-59. PMID: 16175180
44. Loughery J, Meek D. Switching on p53: An essential role for protein phosphorylation? BioDiscovery. 2013; 8: 1.
45. Malhotra P, Anwar M, Nanda N, Kochhar R, Wig JD, Vaiphei K, et al. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians. Tumour Biol. 2013; 34: 1901-11. doi: 10.1007/s13277-013-0734-y PMID: 23526092
46. Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, et al. Mutant p53 prolongs NF-?B activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 2013; 23: 634-46. doi: 10.1016/j.ccr.2013.03.022 PMID: 23680148
47. Webster GA, Perkins ND. Transcriptional cross talk between NF-?B and p53. Mol Cell Biol. 1999; 19: 3485-3495. PMID: 10207072
48. Deveraux Q, Reed J. IAP family proteins-suppressors of apoptosis. Gene Dev. 1999; 13: 239-252. PMID: 9990849
49. Karin M, Cao Y, Greten F, Li Z. NF-?B in cancer: From innocent bystander to major culprit. Nature Rev Cancer. 2002; 2: 301-310.
50. Duivenvoorden WC, Popovic SV, Lhoták S, Seidlitz E, Hirte HW, Tozer RG, et al. Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer. Cancer Res. 2002; 62: 1588-91. PMID: 11912125
51. Fife RS, Sledge GW. Effects of doxycycline on cancer cells in vitro and in vivo. Adv Dent Res. 1998; 12: 94-96. PMID: 9972129